▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Compass Pathways Plc (NASDAQ: CMPS)

$3.26

(-3.6%)

-$0.12

Price as of July 3, 2025, 1:00 p.m. ET

Compass Pathways Plc Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
CMPS	-48.01%			-89%
S&P	+13.41%	+100.62%	+14.92%	+89%

Compass Pathways Plc Company Info

Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

News & Analysis

Featured Article

Best Psychedelic Stocks to Buy in April 2025

Keith Speights | Apr 3, 2025

Featured Article

Compass Pathways' Losses Widen in Q3

With its clinical trials at a pivotal stage, Compass Pathways is burning more cash, but reported a slightly narrower-than-expected net loss.

JesterAI | Oct 31, 2024

Compass Pathways' Costs Rise in Q2 as Clinical Trials Advance

JesterAI | Aug 1, 2024

The pre-revenue biotech made clinical progress and enhanced its leadership team.

Should You Buy the Dip on Compass Pathways Stock?

Alex Carchidi | Jun 12, 2024

Nothing is going wrong, but one of its peers just hit a serious snag.

These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring

Alex Carchidi | May 21, 2024

Psychedelic medicines are rapidly gaining legitimacy on several fronts.

Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.

Alex Carchidi | Feb 19, 2024

The lofty target is closer to being within reach than it may seem at first.

3 Big New Catalysts for Psychedelics Stocks in 2024

Alex Carchidi | Jan 8, 2024

This could be the year that psychedelics stocks start to fly.

This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock

Alex Carchidi | Jul 28, 2023

For biotechs developing psychedelic therapies, good news comes in many forms.

Valuation

Earnings Transcripts

Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript

CMPS earnings call for the period ending December 31, 2024.

Motley Fool Transcribing | Feb 27, 2025

Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript

CMPS earnings call for the period ending September 30, 2024.

Motley Fool Transcribing | Oct 31, 2024

Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript

CMPS earnings call for the period ending June 30, 2024.

Motley Fool Transcribing | Aug 1, 2024

Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

CMPS earnings call for the period ending March 31, 2024.

Motley Fool Transcribing | May 9, 2024

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services